Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy

Coronavirus disease 2019 (COVID-19) is an infectious disease, caused by a newly emerged highly pathogenic virus called novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Targeting the main protease (M(pro), 3CL(pro)) of SARS-CoV-2 is an appealing approach for drug development becaus...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Virus Res
Auteurs principaux: Mohammad, Taj, Shamsi, Anas, Anwar, Saleha, Umair, Mohd., Hussain, Afzal, Rehman, Md. Tabish, AlAjmi, Mohamed F., Islam, Asimul, Hassan, Md. Imtaiyaz
Format: Artigo
Langue:Inglês
Publié: Elsevier B.V. 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7380256/
https://ncbi.nlm.nih.gov/pubmed/32717346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virusres.2020.198102
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires